Clinical trial
Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral…
NCT00399919 · Sigma-Tau Research, Inc., Industry · Completed
Key facts
| NCT number | NCT00399919 |
|---|---|
| Title | Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication) |
| Official title | Safety and Efficacy pf Propionyl-L-Carnitine in Combination With Monitored Exercise Training in Peripheral Arterial Disease (Intermittent Claudication). |
| Lead sponsor | Sigma-Tau Research, Inc., Industry |
| Collaborators | Colorado Prevention Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Diseases, Intermittent Claudication |
| Intervention type | Drug |
| Interventions | Propionyl-L-Carnitine, PLC |
| Enrollment | 69 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Nov 15, 2006 |
| Last update posted | Aug 25, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: